focus -WSS

focus

author：fashion 2025-09-30 17:05:19 - browse：2895

The home health industry lobbying group is suing Medicare over new payment cuts. But profits in the sector remain near all-time highs. Business Insider/AP

The National Association of Home Care and Hospice sued the Biden administration to halt the government’s recent proposed rule that would cut Medicare payments to home health agencies by 2.2% in 2024.

Since 2020, Medicare has updated its system for how it pays for home health, in particular by basing payments less on how much therapy someone is getting at home. By law, the new system can’t cost more or less than it otherwise would have, but Medicare reinforced this year that it had “paid more under the new system than it would have under the old system” — and thus continued cuts to home health for next year.

Newsletters

Sign up for STAT Health Care Inc.

Following the flow of money through the health care industry.

Please enter a valid email address. Privacy Policy

NAHC, the home health industry’s lobbying group, said in its lawsuit that Medicare has been violating the requirement to keep things “budget-neutral” and threatens to put home health operators out of business. But one thing NAHC failed to mention: Profits in the home health industry remain near all-time highs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Paxlovid should be available without a positive Covid test

focus

WSS

Listen: Who gets the credit for GLP

In early work, researchers turn to CRISPR to treat Alzheimer's

Group opposing PBM reform sets lobbying record

Cosmetics set for new safety regulation. Why the industry is on board

WHO recommends dropping component of many flu vaccines

AI can’t replace a physician’s gut feeling

focus

focus

Sign up for STAT Health Care Inc.

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Kaiser Permanente unions announce official strike date

Drug repurposing or repositioning? The language matters

Menendez indictment could see pharma lose a key ally

BioMarin wins approval for gene therapy to treat hemophilia A

STAT Virtual Event: The State of Biosimilars: What to Watch

Wildfire smoke exposes gaps in outdoor worker protections

Why do women spend more than men on medical expenses?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

WHO calls for emergency meeting on new China virus, as cases spread

focus

WHO calls for emergency meeting on new China virus, as cases spread

Key House panel plots a new health care package

Paxlovid should be available without a positive Covid test

Cosmetics set for new safety regulation. Why the industry is on board

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Sanofi seeks simpler, safer CRISPR sickle cell cure

hotspot

focus

Wikipedia

hotspot